Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- ZYNE -17.4%, MRAM -6.4%, SMI -6.4%, NETS -4.6%, HPJ -4.5%, DKS -4.5%,SWCH -4.4%, CLNT -2.5%, PBR -2%, CXRX -1.8%
Other news:
- MYO -6.4% (Myomo announced the filing of registration statement relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase common stock)
- LOXO -6.3% (enters into global collaboration with Bayer (BAYRY) to develop and commercialize larotrectinib and LOXO-195)
- TPRE -6% (commences underwritten secondary public offering of an aggregate of 15,000,000 of the common shares (representing approximately 14.0% of its outstanding shares) by KIA TP Holdings, L.P. and KEP TP Holdings, L.P. )
- PRQR -5% (rices offering of 4,969,805 ordinary shares at $3.25/share)
- ANTH -4.2% (filed for 28,613,474 share common stock offering by the selling stockholders )
- SAGE -4.1% (commences $300 mln common stock offering)
- RPD -1.9% (indicated lower on block trade pricing)
- QUOT -1.4% (commences $175 mln private placement of convertible senior notes due 2022)
- GDI -1.4% (commences 22 mln common stock offering by selling stockholders KKR)
- WTW -1% (intends to offer $500 mln in aggregate principal amount of senior notes due 2025 in a private offering)
Analyst comments:
- PHM -2% (downgraded to Neutral from Buy at Buckingham Research)
- JD -1.5% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- TFX -1.2% (downgraded to Hold from Buy at Deutsche Bank)
- STO -1.1% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- HLT -1% (removed from Conviction Buy List at Goldman)